Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2

被引:21
作者
Mveang Nzoghe, Amandine [1 ]
Essone, Paulin N. [2 ,3 ,4 ]
Leboueny, Marielle [1 ]
Maloupazoa Siawaya, Anicet Christel [1 ]
Bongho, Eliode Cyrien [1 ]
Mvoundza Ndjindji, Ofilia [1 ]
Avome Houechenou, Rotimi Myrabelle [1 ]
Agnandji, Selidji Todagbe [2 ,3 ,4 ]
Djoba Siawaya, Joel Fleury [1 ]
机构
[1] Fdn Jeanne EBORI, CHU Mere Enfant, Serv Lab, Unite Rech & Diagnost Specialise, BP212, Libreville, Gabon
[2] Ctr Recherches Med Lambarene, Lambarene, Gabon
[3] Univ Tubingen, Inst Trop Med, Tubingen, Germany
[4] Univ Tubingen, German Ctr Infect Res, Tubingen, Germany
关键词
D O I
10.1002/iid3.367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged throughout the world. Building knowledge around Covid-19 is crucial to devise facts based approaches to respond efficiently against this pandemic. Aim: We aimed to investigate pre-existing humoral cross-reactive immunity to SARS-CoV-2. Method: We have tested the reactivity against SARS-CoV-2 nucleocapsid (N) antigen of sera collected from healthy healthcare volunteers in 2014. We assessed immunoglobulins reactive against SARS-CoV-2 N-antigen using a well-validated serological platform; Elecsys assay. Results: Sera from 32 subjects (out of 135 [23.7%]) were reactive to SARS-CoV-2 N-antigen, suggesting the presence of anti-SARS-CoV-2 N-antigen antibodies. Conclusion: Although the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 13 条
[1]  
Assis RRd, 2020, BIORXIV
[2]   Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination [J].
Bradt, Victoria ;
Malafa, Stefan ;
von Braun, Amrei ;
Jarmer, Johanna ;
Tsouchnikas, Georgios ;
Medits, Iris ;
Wanke, Kerstin ;
Karrer, Urs ;
Stiasny, Karin ;
Heinz, Franz X. .
NPJ VACCINES, 2019, 4 (1)
[3]   Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer [J].
Chan, Clarence W. ;
Parker, Kyle ;
Tesic, Vera ;
Baldwin, Angel ;
Tang, Nga Yeung ;
van Wijk, Xander M. R. ;
Yeo, Kiang-Teck J. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (05) :620-626
[4]   M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis [J].
Essone, Paulin N. ;
Leboueny, Marielle ;
Siawaya, Anicet Christel Maloupazoa ;
Alame-Emane, Amel Kevin ;
Biyogo, Oriane Cordelia Aboumegone ;
Tadatsin, Patrice Hemery Dapnet ;
Nzoghe, Amandine Mveang ;
Essamazokou, Dimitri Ulrich ;
Ndjindji, Ofilia Mvoundza ;
Padzys, Guy-Stephane ;
Agnandji, Selidji Todagbe ;
Takiff, Howard ;
Gicquel, Brigitte ;
Siawaya, Joel Fleury Djoba .
SCIENTIFIC REPORTS, 2019, 9 (1)
[5]  
Grzelak L, 2020, SARS COV 2 SEROLOGIC, DOI 10.1101/2020. 04.21.20068858.
[6]   Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. [J].
Hancock, Kathy ;
Veguilla, Vic ;
Lu, Xiuhua ;
Zhong, Weimin ;
Butler, Ebonee N. ;
Sun, Hong ;
Liu, Feng ;
Dong, Libo ;
DeVos, Joshua R. ;
Gargiullo, Paul M. ;
Brammer, T. Lynnette ;
Cox, Nancy J. ;
Tumpey, Terrence M. ;
Katz, Jacqueline M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (20) :1945-1952
[7]   Humoral Immune Response to SARS-CoV-2 Comparative Clinical Performance of Seven Commercial Serology Tests [J].
Herroelen, Pauline H. ;
Martens, Geert A. ;
De Smet, Dieter ;
Swaerts, Koen ;
Decavele, An-Sofie .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (05) :610-619
[8]   Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2 [J].
Muench, Peter ;
Jochum, Simon ;
Wenderoth, Verena ;
Ofenloch-Haehnle, Beatus ;
Hombach, Michael ;
Strobl, Matthias ;
Sadlowski, Henrik ;
Sachse, Christopher ;
Torriani, Giulia ;
Eckerle, Isabella ;
Riedel, Alexander .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (10)
[9]  
Roche Diagnostics, 2020, EL ANT SARS COV 2
[10]   Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells [J].
Saron, Wilfried A. A. ;
Rathore, Abhay P. S. ;
Ting, Lim ;
Ooi, Eng Eong ;
Low, Jenny ;
Abraham, Soman N. ;
St John, Ashley L. .
SCIENCE ADVANCES, 2018, 4 (07)